JPMorgan China Growth & Income Trust
Can China’s recovery continue to defy expectations?
China’s equity rally rekindled — but for how long?
Will ‘Year of the Snake’ be good or bad news for China?
Which sector should investors back in 2025?
Valuation focus needed ahead of more policy measures
Contrarian China: unravelling investment potential
Four reasons to back Chinese equities at their nadir
The potential risks and outlook for Chinese equities in 2022